Skip to content

Clinical trials

Respiratory Syncytial Virus Infections trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Syncytial Virus Infections Country / region: United Kingdom Clear all

53 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20061
20101
20112
20122
20132
20145
20154
20162
20175
20185
20196
20205
20217
20221
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed42
Terminated7
Active, not recruiting2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline6
Imperial College London4
Pfizer4
Alios Biopharma Inc.3
AstraZeneca3
Enanta Pharmaceuticals, Inc3
MedImmune LLC3
Gilead Sciences2
Hvivo2
Janssen Sciences Ireland UC2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Syncytial Virus Infections53
Bronchiolitis4
Influenza, Human4
Infections2
Virus Diseases2
Adenoviridae Infections1
Arrhythmias, Cardiac1
Bronchiolitis, Viral1
COVID-191
Cardiovascular Diseases1

Trials

Showing 1 to 25 of 53. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.